7-Azaindole,271-63-6,3240-34-4,Paclitaxel,33069-62-4

7-Azaindole 271-63-6 MFCD00005606

Diethyl (tosyloxy)methylphosphonate 31618-90-3 MFCD03412078

(Diacetoxyiodo)benzene 3240-34-4 MFCD00008692

6-Methylpyridine-3-carboxylic acid 3222-47-7 MFCD00006341

9,9-Bis(4-hydroxyphenyl)fluorene 3236-71-3 MFCD00191392

Paclitaxel 33069-62-4 MFCD00869953
Paclitaxel  is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a U.S. National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it taxol. When it was developed commercially by Bristol-Myers Squibb (BMS) the generic name was changed to paclitaxel and the BMS compound is sold under the trademark TAXOL. In this formulation, paclitaxel is dissolved in Cremophor EL and ethanol, as a delivery agent. A newer formulation, in which paclitaxel is bound to albumin, is sold under the trademark Abraxane.
(S)-(-)-2-Chloropropionic acid 29617-66-1 MFCD00064205

2-Bromo-9,9-dimethylfluorene 28320-31-2 NULL